ONCOSIL MEDICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.007 AUD | 0.00% |
|
+16.67% | -22.22% |
| Jun. 11 | OncoSil Medical Treats Fifth Pancreatic Cancer Patient with Proprietary Device | MT |
| Jun. 03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 16.16M | - | - | - | - | - | |
| 854B | ||||||
| 636B | ||||||
| 361B | ||||||
| 324B | ||||||
| 301B |
